https://www.bioworld.com/rss en-us Nature on June 21, 2023, suggest ways to bring B cells into the antitumor fight. More broadly, Lloyd Bod told BioWorld, his laboratory aims to “break the dogma that B cells only produce antibodies.”]]> http://www.bioworld.com/articles/698431 Wed, 28 Jun 2023 09:00:00 -0400 https://www.bioworld.com/articles/698431-b-cells-get-in-on-the-immune-checkpoint-fray http://www.bioworld.com/articles/696287 Fri, 21 Apr 2023 09:00:00 -0400 https://www.bioworld.com/articles/696287-tissue-resident-memory-cells-in-lung-may-drive-lung-cancer-in-smokers Tissue-resident memory T cells in the lung of smoker patients Immunofluorescence shows the presence of tissue-resident memory T cells (TRMs) in the lung of smoker patients. The TRM cells are represented in aqua and red, the lung airways are depicted in pink, and the cell nuclei are depicted in dark blue. Credit: WEHI researchers http://www.bioworld.com/articles/434497 Fri, 17 Apr 2020 13:00:00 -0400 https://www.bioworld.com/articles/434497-for-gliomas-hypermutated-does-not-mean-sensitive-to-checkpoint-blockade Keith Ligon, chief of neuropathology, Brigham and Women's Hospital Keith Ligon, chief of neuropathology at Brigham and Women’s Hospital. Credit: Dana-Farber Cancer Institute http://www.bioworld.com/articles/434436 Wed, 15 Apr 2020 12:00:00 -0400 https://www.bioworld.com/articles/434436-for-gliomas-hypermutated-does-not-mean-sensitive-to-checkpoint-blockade Keith Ligon, chief of neuropathology, Brigham and Women's Hospital Keith Ligon, chief of neuropathology at Brigham and Women’s Hospital. Credit: Dana-Farber Cancer Institute